Skip to Main Content

Paper Details

Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial.
Eur Urol
3
2024
Androgen, PSA, Prostate Cancer, androgen, cancer, localised prostate cancer, noncancer, patients, prostate cancer, prostate-specific antigen
Author NameAffiliation
Stephanie L Pugh
Christopher U JonesSutter Medical Center Sacramento
Jeff M MichalskiWashington University School of Medicine
Mack RoachUCSF Medical Center-Mount Zion
Thomas M PisanskyMayo Clinic
Eric M HorwitzFox Chase Cancer Center
Felix Y FengUCSF Medical Center-Mount Zion
  • 1 - 7

Datasets